US Patent Issued to TauC3 Biologics on Oct. 27 for "Treatment of tauopathies" (New York Inventor)

ALEXANDRIA, Va., Oct. 27 -- United States Patent no. 12,774,322, issued on Oct. 27, was assigned to TauC3 Biologics Ltd. (London).

"Treatment of tauopathies" was invented by Daniel G. Chain (New York).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention is directed to methods of treatment of Alzheimer's disease and other tauopathies, via the administration of antibodies having specificity to abnormal forms of tau protein, the antibodies showing no binding and/or reactivity to a normal tau protein and being administered under conditions and in amounts effective to prevent or treat Alzheimer's disease or other tauopathies. In certain embodiments, the antibodies are selective for soluble truncated tau pr...